-
Native Protein Gel Electrophoresis: Quantitative Advances wi
2026-06-04
Explore how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit empowers precise, native-state protein analysis. This article uniquely bridges quantitative methodology with translational assay design, offering advanced insights beyond standard workflows.
-
Angiotensin II (A1042): Protocols for Vascular Research Mode
2026-06-04
Angiotensin II enables precise modeling of hypertension, cardiovascular remodeling, and vascular smooth muscle cell hypertrophy in both cell-based and animal systems. This product is optimal for researchers requiring reproducible induction of vascular responses, but should not be used for diagnostic or clinical applications.
-
YAP-TEAD Drives PPARα-Induced Hepatomegaly and Liver Regener
2026-06-03
This study uncovers a mechanistic link between PPARα activation and the YAP-TEAD transcriptional module in promoting hepatomegaly and liver regeneration in mice. The findings establish the YAP-TEAD pathway as a necessary mediator of PPARα-driven hepatic growth, informing future research on metabolic regulation and liver repair.
-
Scalable Production of EPSC-Induced MSC-EVs: Bioreactor Adva
2026-06-03
Gong et al. present a scalable, standardized bioreactor platform for producing extracellular vesicles (EVs) from extended pluripotent stem cell-derived mesenchymal stem cells (EPSC-iMSCs). This approach addresses key limitations of conventional MSC-EV manufacturing, enabling reproducible, GMP-compliant EV yields with demonstrated therapeutic efficacy in pulmonary fibrosis models.
-
Reactive Oxygen Species Assay Kit: Optimizing Live-Cell ROS
2026-06-02
Quantify oxidative stress in real time with the APExBIO Reactive Oxygen Species Assay Kit, leveraging the DCFH-DA fluorescent probe for high-sensitivity live-cell analysis. This guide demystifies experimental workflows and provides actionable troubleshooting tips inspired by translational research breakthroughs.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-06-02
This article examines how naturally occurring angiotensin peptides, including N-terminally truncated forms such as Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to its receptor AXL. These findings suggest a new mechanistic link between the renin-angiotensin system and viral entry pathways, with practical implications for both cardiovascular and infectious disease research.
-
WY-14643 (Pirinixic Acid): Applied Workflows for Metabolic R
2026-06-01
WY-14643 (Pirinixic Acid) enables precise dissection of PPARα-driven metabolic and inflammatory pathways, offering robust, reproducible modeling for metabolic disorder and tumor microenvironment studies. This guide delivers actionable workflows, troubleshooting strategies, and protocol insights to maximize the scientific value of APExBIO's selective PPARα agonist.
-
Optimizing MTT for In Vitro Cell Proliferation Assays
2026-06-01
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) stands out as a robust, high-purity reagent for colorimetric evaluation of cell viability and proliferation. This guide translates current research, including novel EMT insights, into actionable workflows and troubleshooting strategies for advanced biomedical applications.
-
Soluble PD-L1 Induction by Wnt/β-Catenin in Glioma Suppresse
2026-05-31
This study demonstrates that glioma cells generate soluble PD-L1 (sPD-L1) via Wnt/β-catenin signaling, which suppresses CD8+ T cell activity and correlates with tumor burden. The findings highlight sPD-L1 as a prognostic biomarker and provide a rationale for combined Wnt and PD-L1 inhibition in glioma immunotherapy.
-
TAK-715: p38 MAPK Inhibitor for Precision Inflammation Resea
2026-05-30
TAK-715, a potent p38 MAPK inhibitor from APExBIO, delivers unmatched selectivity and dual-action modulation of kinase signaling—making it a gold standard for dissecting inflammatory and cytokine pathways. With data-driven protocol flexibility and proven anti-inflammatory efficacy, TAK-715 redefines experimental workflows in rheumatoid arthritis and chronic disease models.
-
WY-14643 (Pirinixic Acid): PPARα Agonism in Translational Re
2026-05-29
This thought-leadership article provides translational researchers with a mechanistic and strategic deep dive into WY-14643 (Pirinixic Acid), a potent and selective PPARα agonist. Integrating new multiomics evidence on linoleic acid–driven tumor progression, it offers actionable guidance for deploying WY-14643 across metabolic and oncologic research, while situating APExBIO's offering in a competitive and clinical context.
-
D-Luciferin and Bioluminescence: Driving Translational Oncol
2026-05-29
Explore how D-Luciferin, a high-affinity firefly luciferase substrate, empowers translational oncology through mechanistic insight, robust protocols, and strategic guidance for researchers tackling metastasis and tumor burden. This thought-leadership article bridges foundational biochemistry, experimental best practices, and clinical relevance, while offering a forward-looking perspective on non-invasive bioluminescence imaging.
-
WY-14643 (Pirinixic Acid): Applied Protocols in Metabolic Re
2026-05-28
WY-14643 (Pirinixic Acid) stands out as a versatile PPARα agonist for metabolic disorder and inflammation research, offering robust dual PPARα/γ activity and quantifiable effects on lipid and glucose metabolism. This article delivers actionable protocols, advanced applications, and troubleshooting guidance to maximize reproducibility and scientific insight using APExBIO's high-quality WY-14643.
-
Nitrocefin: Chromogenic Cephalosporin Substrate in β-Lactama
2026-05-28
Nitrocefin empowers researchers with rapid, visually distinct colorimetric β-lactamase detection, streamlining multidrug resistance profiling and inhibitor screening. Its robust performance and straightforward workflow make it the gold standard for both basic and advanced applications in antibiotic resistance research.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Protocols & QC Guid
2026-05-27
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody is designed for sensitive, specific detection of rabbit IgG in immunofluorescence, immunohistochemistry, and related assays. It is best suited for workflows requiring clear signal amplification and minimal cross-reactivity. Applications outside research use, or in diagnostic/clinical settings, are not supported based on current product specifications.